Kineta Shares Outstanding 2014-2024 | KANT
Kineta shares outstanding from 2014 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Kineta Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
11 |
| 2022 |
5 |
| 2021 |
4 |
| 2020 |
0 |
| 2019 |
0 |
| 2018 |
0 |
| 2017 |
0 |
| 2016 |
0 |
| 2015 |
0 |
| 2014 |
0 |
| 2013 |
0 |
Kineta Quarterly Shares Outstanding
(Millions of Shares) |
| 2024-06-30 |
13 |
| 2024-03-31 |
11 |
| 2023-12-31 |
11 |
| 2023-09-30 |
12 |
| 2023-06-30 |
10 |
| 2023-03-31 |
8 |
| 2022-12-31 |
5 |
| 2022-09-30 |
5 |
| 2022-06-30 |
5 |
| 2022-03-31 |
5 |
| 2021-12-31 |
4 |
| 2021-09-30 |
1 |
| 2021-06-30 |
1 |
| 2021-03-31 |
1 |
| 2020-12-31 |
0 |
| 2020-09-30 |
0 |
| 2020-06-30 |
0 |
| 2020-03-31 |
0 |
| 2019-12-31 |
0 |
| 2019-09-30 |
0 |
| 2019-06-30 |
0 |
| 2019-03-31 |
0 |
| 2018-12-31 |
0 |
| 2018-09-30 |
0 |
| 2018-06-30 |
0 |
| 2018-03-31 |
0 |
| 2017-12-31 |
0 |
| 2017-09-30 |
0 |
| 2017-06-30 |
0 |
| 2017-03-31 |
0 |
| 2016-12-31 |
0 |
| 2016-09-30 |
0 |
| 2016-06-30 |
0 |
| 2016-03-31 |
0 |
| 2015-12-31 |
0 |
| 2015-09-30 |
0 |
| 2015-06-30 |
0 |
| 2015-03-31 |
0 |
| 2014-12-31 |
|
| 2013-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.005B |
|
Kineta, Inc. is a clinical-stage biotechnology company. It develops next-generation immunotherapies that address the major challenges with current cancer therapy. The company's lead asset is KVA12123, a novel VISTA blocking immunotherapy. Kineta merged with Yumanity Therapeutics, Inc., and is based in Seattle.
|
